Overview
Heart defect-tongue hamartoma-polysyndactyly syndrome, also known as oral-facial-digital syndrome type IV (OFD IV) or Mohr-Majewski syndrome, is an extremely rare congenital malformation syndrome characterized by the combination of congenital heart defects, hamartomas (benign tumor-like growths) of the tongue, and polysyndactyly (extra digits that may also be fused together). This condition affects multiple body systems including the cardiovascular system, the oral cavity, and the skeletal system, particularly the hands and feet. Additional features may include other oral findings such as lobulated tongue, lingual nodules, and cleft palate or lip, as well as various limb anomalies including tibial dysplasia and short limbs. The condition is present at birth and is typically recognized in the neonatal period based on the characteristic combination of physical findings. Congenital heart defects associated with this syndrome can vary in type and severity. The skeletal abnormalities, particularly polysyndactyly, are among the most recognizable features. Some patients may also exhibit facial dysmorphism and central nervous system anomalies. Treatment is symptomatic and supportive, as there is no cure for the underlying condition. Management typically involves a multidisciplinary approach including cardiac surgery or intervention for significant heart defects, surgical correction of polysyndactyly and other limb anomalies, and removal of tongue hamartomas if they interfere with feeding or breathing. Prognosis depends largely on the severity of the cardiac and other organ involvement. Genetic counseling is recommended for affected families.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Heart defect-tongue hamartoma-polysyndactyly syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Heart defect-tongue hamartoma-polysyndactyly syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Heart defect-tongue hamartoma-polysyndactyly syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Heart defect-tongue hamartoma-polysyndactyly syndrome.
Community
No community posts yet. Be the first to share your experience with Heart defect-tongue hamartoma-polysyndactyly syndrome.
Start the conversation →Latest news about Heart defect-tongue hamartoma-polysyndactyly syndrome
No recent news articles for Heart defect-tongue hamartoma-polysyndactyly syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Heart defect-tongue hamartoma-polysyndactyly syndrome
What is Heart defect-tongue hamartoma-polysyndactyly syndrome?
Heart defect-tongue hamartoma-polysyndactyly syndrome, also known as oral-facial-digital syndrome type IV (OFD IV) or Mohr-Majewski syndrome, is an extremely rare congenital malformation syndrome characterized by the combination of congenital heart defects, hamartomas (benign tumor-like growths) of the tongue, and polysyndactyly (extra digits that may also be fused together). This condition affects multiple body systems including the cardiovascular system, the oral cavity, and the skeletal system, particularly the hands and feet. Additional features may include other oral findings such as lobu
How is Heart defect-tongue hamartoma-polysyndactyly syndrome inherited?
Heart defect-tongue hamartoma-polysyndactyly syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Heart defect-tongue hamartoma-polysyndactyly syndrome typically begin?
Typical onset of Heart defect-tongue hamartoma-polysyndactyly syndrome is neonatal. Age of onset can vary across affected individuals.